{
    "2019-02-11": [
        [
            {
                "time": "",
                "original_text": "医药生物行业周报：蓄力待发展望长期机遇",
                "features": {
                    "keywords": [
                        "医药",
                        "生物",
                        "周报",
                        "蓄力",
                        "长期机遇"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "【国信医药丨行业重大事件快评】静丙艾滋抗体阳性事件尚需静待最终调查结果",
                "features": {
                    "keywords": [
                        "国信医药",
                        "静丙",
                        "艾滋抗体",
                        "阳性",
                        "调查结果"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "头号研报：2018年A股业绩预告总结",
                "features": {
                    "keywords": [
                        "头号研报",
                        "2018",
                        "A股",
                        "业绩预告",
                        "总结"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "A股"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "报告 | 2018年河南省上市公司市值TOP50",
                "features": {
                    "keywords": [
                        "报告",
                        "2018",
                        "河南省",
                        "上市公司",
                        "市值",
                        "TOP50"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "河南省上市公司"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "A股迎春 暖意浓浓",
                "features": {
                    "keywords": [
                        "A股",
                        "迎春",
                        "暖意浓浓"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "A股"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-02-10",
                "original_text": "【医药】江琦、王超（研究助理）：2月月报：信心正逐步恢复、Q1建议关注创新药、原料药和商业板块 - 20190210",
                "features": {
                    "keywords": [
                        "医药",
                        "江琦",
                        "王超",
                        "2月月报",
                        "信心恢复",
                        "创新药",
                        "原料药",
                        "商业板块"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "创新药",
                        "原料药",
                        "商业板块"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "修美乐连续7年销量全球第一 潜在市场空间巨大(附股)",
                "features": {
                    "keywords": [
                        "修美乐",
                        "销量",
                        "全球第一",
                        "潜在市场空间",
                        "附股"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}